Alliance Responds to Angelina Jolie's BRCA1 Announcement

Actress Angelina Jolie recently announced that she carries a mutation in the BRCA1 gene, which makes her more likely to develop breast and ovarian cancer. In the wake of that news, many media outlets reached out to the Ovarian Cancer National Alliance for commentary and perspective.

Our CEO, Calaneet Balas, wrote a letter to the New York Times praising Ms. Jolie for starting a conversation about genetic risks of breast and ovarian cancers. Read the letter here (last letter on page; subscription required).

Our staff also spoke with US News and World Report. The Washington Post mentioned our work with actress Kathy Bates, a breast and ovarian cancer survivor, in a slideshow about celebrities who advocate for diseases. Watch our PSA with Kathy Bates!

Posted on in Community, OCRA News